General Information
Originality and copyright
To be considered for publication in J DOHaD, a manuscript cannot have been published previously, nor can it be under review for publication elsewhere. (Previously published figures may be sparingly used in Reviews, with appropriate permission.) The posting of a brief summary of clinical trial outcomes on a pharmaceutical website (such as the PhRMA-sponsored database www.clinicalstudyresults.org) will not necessary count as prior publication nor impede full consideration of a manuscript: J DOHaD will look at this on a case-by-case basis to determine the extent of overlap between the trial data posted and the manuscript as submitted, and will decide whether the manuscript contains a sufficiently new perspectives or sufficient additional data for it to count as original. Authors should declare when submitting manuscripts that such data have already been posted and J DOHaD will review this sympathetically.
Papers with multiple authors are reviewed with the assumption that all authors have contributed materially to the research reported, have approved the submitted manuscript and concur with its submission to J DOHaD.
Author Publication Agreement
The policy of Developmental Origins of Health and Disease is that authors (or in some cases their employers) retain copyright and grant the International Society for Developmental Origins of Health and Disease a licence to publish their work. In the case of gold open access articles this is a non-exclusive licence. Authors must complete and return an author publishing agreement form as soon as their article has been accepted for publication; the journal is unable to publish the article without this. Please download the appropriate publishing agreement here.
For open access articles, the form also sets out the Creative Commons licence under which the article is made available to end users: a fundamental principle of open access is that content should not simply be accessible but should also be freely re-usable. Articles will be published under a Creative Commons Attribution license (CC-BY) by default. This means that the article is freely available to read, copy and redistribute, and can also be adapted (users can “remix, transform, and build upon” the work) for any commercial or non-commercial purpose, as long as proper attribution is given. Authors can, in the publishing agreement form, choose a different kind of Creative Commons license (including those prohibiting non-commercial and derivative use) if they prefer.
Authorship
All individuals included as authors of papers must have contributed substantially to the scientific process leading up to the writing of the paper. Such contribution includes the conception and design of the project, the performance of experiments and the analysis and interpretation of data. In addition the author should have made a substantial contribution to drafting or critical revision of the manuscript for important intellectual content.
We are aware that authors sometimes receive assistance from technical writers, language editors and/or writing agencies in preparing manuscripts for publication. Such assistance must be noted in the cover letter and in the Acknowledgements section along with a declaration that the author(s) are entirely responsible for the scientific content of the paper.
Failure to acknowledge assistance from technical writers, language editors and/or writing agencies in preparing manuscripts for publication in the Acknowledgements section may lead to disqualification of the paper.
Under no circumstances will J DOHaD accept submissions by writing or editorial agencies on behalf of authors and there will be no correspondence with writing or editorial agencies regarding submitted or revised manuscripts.
Policy on prior publication
When authors submit manuscripts to this journal, these manuscripts should not be under consideration, accepted for publication or in press within a different journal, book or similar entity, unless explicit permission or agreement has been sought from all entities involved. However, deposition of a preprint on the author’s personal website, in an institutional repository, or in a preprint archive shall not be viewed as prior or duplicate publication. Authors should follow the Cambridge University Press Preprint Policy regarding preprint archives and maintaining the version of record.
English language editing services
Authors, particularly those whose first language is not English, may wish to have their English-language manuscripts checked by a native speaker before submission. This step is optional, but may help to ensure that the academic content of the paper is fully understood by the Editor and any reviewers.
In order to help prospective authors to prepare for submission and to reach their publication goals, Cambridge University Press offers a range of high-quality manuscript preparation services – including language editing – delivered in partnership with American Journal Experts. You can find out more on our Language Services page.
Please note that the use of any of these services is voluntary, and at the author's own expense. Use of these services does not guarantee that the manuscript will be accepted for publication, nor does it restrict the author to submitting to a Cambridge-published journal.
Competing Interests
All authors must include a competing interest declaration in their main manuscript file. This declaration will be subject to editorial review and may be published in the article.
Competing interests are situations that could be perceived to exert an undue influence on the content or publication of an author’s work. They may include, but are not limited to, financial, professional, contractual or personal relationships or situations.
If the manuscript has multiple authors, the author submitting must include competing interest declarations relevant to all contributing authors.
Example wording for a declaration is as follows: “Competing interests: Author 1 is employed at organisation A, Author 2 is on the Board of company B and is a member of organisation C. Author 3 has received grants from company D.” If no competing interests exist, the declaration should state “Competing interests: The author(s) declare none”.
Authorship and contributorship
All authors listed on any papers submitted to this journal must be in agreement that the authors listed would all be considered authors according to disciplinary norms, and that no authors who would reasonably be considered an author have been excluded. For further details on this journal’s authorship policy, please see this journal's publishing ethics policies.
Author affiliations
Author affiliations should represent the institution(s) at which the research presented was conducted and/or supported and/or approved. For non-research content, any affiliations should represent the institution(s) with which each author is currently affiliated.
For more information, please see our author affiliation policy and author affiliation FAQs.
Manuscript preparation and style
The manuscript should be typed double-spaced throughout on 'Letter' or A4 paper. Pages should be numbered sequentially beginning with the Title Page. Margins should not be less than 2.5cm on all sides and the font should be clearly legible and uniform throughout.
A Short Title of up to forty-five characters should be provided on the title page and should be repeated at the top right of every following page. The names of the authors (e.g. Smith et al. or Smith and Jones) should be given at the top left of every page besides the title page.
The Abstract should be unstructured (i.e., no sub-headings) but must provide the reader with a self-contained summary of the paper. It should include a brief introduction to the paper, the method, the key findings, and the conclusions. A list of 3–5 key words or terms for indexing should follow the abstract.
The Body of the Manuscript should begin on page 3. For Regular Original Articles, Brief Reports, the formal should include: Introduction, Method, Results, Discussion and Acknowledgements. These should be followed on a new page by the References.
Tables should be consecutively numbered as they appear in the text (Table 1, etc.). Each Table should be typed on a separate sheet with the Table number and heading above and any note below.
Figures should be consecutively numbered as they appear in the text (Figure 1, 2 etc). Use italic letters for parts a, b, c etc. Use abbreviation (Fig), except where starting a new sentence. Legends should be provided for each Figure. Scale bars should be added to photomicrographs and other similar images. Figures (scale bars, pie charts, etc) should be presented in two dimensions only.
All figures submitted to Journal of Developmental Origins of Health and Disease will be published in colour on Cambridge Core Online free of charge.
How to Ensure Colour Online
To maximize the probability that figures will be published in colour, authors are encouraged to follow these figure submission guidelines:
• Submit a colour graphic as either TIFF or EPS files
• Submit figures at approximately the size at which they are to reproduce so that reduction or enlargement is not necessary.
• Line artwork should be supplied in black and white mode at a resolution of 1200 dpi; combination artwork (line/tone) at a resolution of 800 dpi; black and white halftone artwork should be saved in ‘grayscale’ mode at a resolution of 300dpi; colour halftone artwork should be saved in CMYK mode at a resolution of 400 dpi.
• Submit multipart figures in one single electronic file.
Author Requirements
It is not necessary for authors to indicate that a figure should be displayed in colour. Cambridge Core will assume that any author who submits figures in colour wants and agrees to their being produced in colour online. It is the author’s responsibility to declare otherwise. Colour figures must be submitted before the paper is accepted for publication, and cannot be received later in the process.
Exceptions to Free Colour:
• Colour figures submitted to Journal of Developmental Origins of Health and Disease will be published in colour free of charge with the following exceptions:
• The colour figure file is deemed unusable due to production standards or poor colour quality and must be converted to black and white.
• The author gives explicit instructions to convert the colour figure to black and white.
What to Expect
Authors will see these colour figures when viewing their author page proofs on screen. Authors will NOT be allowed to submit colour figures to replace black and white figures in the page proof stage.
The use of Abbreviations, except those that are widely used, is strongly discouraged. They should be used only if they contribute to better comprehension of the manuscript. Acronyms should be spelled out at first mention. Metric system (SI) units should be used.
J DOHaD encourages submissions from all over the world. Authors who are not fluent in written English are encouraged to seek assistance in this regard before submitting their manuscripts.
Acknowledgements
Here you may acknowledge individuals or organisations that provided advice and/or support (non-financial). Formal financial support and funding should be listed in the following section.
The Acknowledgements should be placed after the main body of the text before Financial Support. If there are no Acknowledgements, the title should be inserted followed by "None". Papers that do not include an Acknowledgements section will not be reviewed.
Financial Support
Please provide details of the sources of financial support for all authors, including grant numbers. This is particularly important in the case of research that is supported by industry. Support from industry not only includes direct financial support for the study but also support in kind such as provision of medications, equipment, kits or reagents without charge or at reduced cost and provision of services such as statistical analysis. For example, "This work was supported by the Medical research Council (grant number XXXXXXX)". Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with "and" before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors’ initials. For example, "This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH)". Where no specific funding has been provided for research, please provide the following statement: "This research received no specific grant from any funding agency, commercial or not-for-profit sectors."
The Financial Support statement should be placed after the Acknowledgements and before the Conflicts of Interest section. Papers that do not include a Financial Support statement will not be reviewed.
Conflicts of Interest
Conflict of interest exists when an author has interests that might inappropriately influence his or her judgement, even if that judgement is not influenced. Because of this, authors must disclose potentially conflicting interests so that others can make judgements about such effects. At the time of submission authors should disclose any financial arrangements or connections they may have that are pertinent to the submitted manuscript and that may be perceived as potentially biasing their paper. Non-financial interests that could be relevant in this context should also be disclosed. If no relevant interests exist, this should be stated. This requirement applies to all the authors of a paper and to all categories of papers including letters to the editor.
The Conflicts of Interest section should be placed after Financial Support. If there are no interests to declare, the title should be inserted followed by "None".
Papers that do not include a Conflicts of Interest section will not be reviewed.
Ethical Standards
Where research involves human and/or animal experimentation, the following statements should be included (as applicable): "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation (please name) and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by the institutional committees (please name) ." and "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guides on the care and use of laboratory animals (please name) and has been approved by the institutional committee (please name)."
The Ethical Standards statement should be placed after the Conflicts of Interest section before the References. If the research does not involve human and/or animal experimentation, this statement should be omitted. Papers reporting the results of human and/or animal experimentation that do not contain an Ethical Standards statement will not be reviewed. For more information on the ethical standards and procedures of Cambridge Core, please visit https://www.cambridge.org/core/services/authors/publishing-ethics.
The requirements of DOH are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals produced by the ICMJE, and authors are encouraged to consult the latest guidelines, which contain useful, general information about preparing scientific papers.
For more specialised instances of the type of trials used in your paper, please see more specific guidelines below.
Animal studies
For studies involving laboratory animals, authors should consult the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines (http://www.nc3rs.org.uk/arrive-guidelines).
Systematic Review/Meta-Analyses
For systematic reviews and meta-analyses, authors should consult the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement (www.prisma-statement.org/). This policy includes all systematic reviews, including those for observational studies.
Randomised trials
For reporting results of randomised trials, authors should consult the CONSORT Statement (http://www.consort-statement.org/), which is an evidence-based, minimum set of recommendations for reporting randomized trials.
Supplemental on-line material
The online platform gives authors the opportunity to include data that would be impossible or impractical to include in the printed version. These data might substantially enhance the importance of the research and might also be of benefit to readers. Authors may include tables and figures as well as data such as videos, 3-D structures/images, extensive datasets and any other supplementary material not suitable for print duplication. All supplementary material must be submitted with the original manuscript. Supplementary data should be referred to in the text with the prefix "S" (e.g. Supplementary Table S1, Supplementary Figure S1). Supplementary files will not be copy-edited, and will be published as supplied.
References
References should be numbered consecutively (in superscript) as they appear in the text. Type the reference list with double-spacing on a separate sheet. References (using Index Medicus abbreviations) should appear in the style as demonstrated below. Please note that if six authors or more, the first three authors should be listed and then ‘et al.’. Examples:
1. Burdge GC, Slater-Jefferies J, Torrens C, et al. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br J Nutr. 2007; 97, 435-439.
2. Gilbert JS, Nijland MJ. Sex differences in the developmental origins of hypertension and cardiorenal disease. Am J Physiol Regul Integr Comp Physiol. 2008; 295, 1941-1952.
3. Mitchell M, Schulz SL, Armstrong DT, Lane M. Metabolic and Mitochondrial Dysfunction in Early Mouse Embryos Following Maternal Dietary Protein Intervention. Biol Reprod. 2009 [Epub ahead of print].
4. Gluckman PD, Hanson MA. The developmental origins of health and disease: an overview. In Developmental Origins of Health and Disease (eds. Gluckman P, Hanson M), 2006; pp. 1-5. Cambridge University Press, Cambridge.
For work that is 'in press' i.e., accepted for publication but not yet published, '(In Press)' should be written in parenthesis and not the year of expected publication.
Proofs
The publisher reserves the right to copy-edit manuscripts. The corresponding author will receive page proofs for final proofreading. These should be checked and returned within 2 days of receipt. The publisher reserves the right to charge authors for excessive correction of non-typographical errors.
Offprints
The corresponding author will receive a PDF file of the article when it is published.
ORCID
We require all corresponding authors to identify themselves using ORCID when submitting a manuscript to this journal. ORCID provides a unique identifier for researchers and, through integration with key research workflows such as manuscript submission and grant applications, provides the following benefits:
- Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you have authored.
- Convenience: As more organisations use ORCID, providing your iD or using it to register for services will automatically link activities to your ORCID record, and will enable you to share this information with other systems and platforms you use, saving you re-keying information multiple times.
- Keeping track: Your ORCID record is a neat place to store and (if you choose) share validated information about your research activities and affiliations.
See our ORCID FAQs for more information.
If you don’t already have an iD, you will need to create one if you decide to submit a manuscript to this journal. You can register for one directly from your user account on ScholarOne, or alternatively via https://ORCID.org/register.
If you already have an iD, please use this when submitting your manuscript, either by linking it to your ScholarOne account, or by supplying it during submission using the "Associate your existing ORCID iD" button.
ORCIDs can also be used if authors wish to communicate to readers up-to-date information about how they wish to be addressed or referred to (for example, they wish to include pronouns, additional titles, honorifics, name variations, etc.) alongside their published articles. We encourage authors to make use of the ORCID profile’s “Published Name” field for this purpose. This is entirely optional for authors who wish to communicate such information in connection with their article. Please note that this method is not currently recommended for author name changes: see Cambridge’s author name change policy if you want to change your name on an already published article. See our ORCID FAQs for more information.
Supplementary materials
Material that is not essential to understanding or supporting a manuscript, but which may nonetheless be relevant or interesting to readers, may be submitted as supplementary material. Supplementary material will be published online alongside your article, but will not be published in the pages of the journal. Types of supplementary material may include, but are not limited to, appendices, additional tables or figures, datasets, videos, and sound files.
Supplementary materials will not be typeset or copyedited, so should be supplied exactly as they are to appear online. Please see our general guidance on supplementary materials for further information.
Where relevant we encourage authors to publish additional qualitative or quantitative research outputs in an appropriate repository, and cite these in manuscripts.
Author Hub
You can find guides for many aspects of publishing with Cambridge at Author Hub, our suite of resources for Cambridge authors.